CIK 0000939767
- Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043257395
- Phone
- +1 650-837-7000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- 4 Planned sale EVP, General Counsel & Sec sold 38,930 shares at $20.01 ($778,989)
- 4 Grant or award President and CEO acquired 313,185 shares (grant or award)
- 4 Grant or award CSO/EVP Disc & Trans Research acquired 68,331 shares (grant or award)
- 4 Grant or award EVP and CFO acquired 85,414 shares (grant or award)
- 4 Grant or award EVP, Prod Dev & Med Aff &CMO acquired 82,566 shares (grant or award)
- 4 Grant or award EVP, Commercial acquired 79,719 shares (grant or award)
- 4 Open-market sale Director sold 15,300 shares at $16.61 ($254,133)
- 4 Open-market sale EVP, General Counsel & Sec sold 77,860 shares at $17.13 ($1,333,742)
- 4 Open-market sale CSO/EVP Disc & Trans Research sold 82,500 shares at $17.50 ($1,443,750)
- 4 Open-market sale Director sold 40,000 shares at $17.49 ($699,600)
- 4 Shares withheld for taxes President and CEO gave up 11,522 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Commercial gave up 1,556 shares (to pay taxes)
- 4 Shares withheld for taxes EVP and CFO gave up 5,278 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, General Counsel & Sec gave up 1,929 shares (to pay taxes)
- 4 Shares withheld for taxes CSO/EVP Disc & Trans Research gave up 1,529 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Prod Dev & Med Aff &CMO gave up 17,299 shares (to pay taxes)
- 4 Open-market sale Director sold 40,000 shares at $17.78 ($711,200)
- 4 Open-market sale EVP, Commercial sold 25,000 shares at $17.37 ($434,250)
- 4 Gift President and CEO gave 37,994 shares (gift)
- 4 Shares withheld for taxes President and CEO gave up 62,006 shares (to pay taxes)
Page 12 of 73 · 1,458 filings